Skip to main content
Year archive

L&K BIOMED CO., LTD. — 2026 filings

All 21 regulatory filings released by L&K BIOMED CO., LTD. (156100) in 2026, sourced directly from the official regulator.

21 Filings
2026 Period
2026 filings (21)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-04-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-04-14 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-20 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-20 Korean
[기재정정]사업보고서 (2025.12)
Annual Report FY 2025
2026-03-12 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-12 Korean
사업보고서 (2025.12)
Annual Report FY 2025
2026-03-12 Korean
주주총회소집공고
AGM Information
2026-02-27 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-02-27 Korean
주주총회소집결의
AGM Information
2026-02-25 Korean
파생상품거래손실발생
Capital/Financing Update
2026-02-19 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2025
2026-02-19 Korean
전환가액의조정
Capital/Financing Update
2026-02-09 Korean
주요사항보고서(자기전환사채매도결정)
Capital/Financing Update
2026-01-27 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2026-01-22 Korean
증권발행결과(자율공시)
Capital/Financing Update
2026-01-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-01-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-01-14 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update
2026-01-09 Korean
전환청구권행사
Capital/Financing Update
2026-01-05 Korean